Demographic data and clinical features of patients
| Patient no. . | Sex/age, y . | Clinical manifestation . | SLEDAI pretransplantation . | Therapy pretransplantation . | Follow-up, mo . | Clinical outcome . | Current therapy . |
|---|---|---|---|---|---|---|---|
| 1 | F/27 | Nephritis, abdominal vasculitis, polyserositis, APS, cytopenia | 25 | CY, AZA, HCQ, CSA, MMF | 96 | Clinical remission | 2 mg prednisolone |
| 2 | F/48 | Nephritis, peripheral neuropathy, polyserositis, ventricular arrhythmia | 23 | CY, AZA, HCQ, MTX, MMF | 96 | Clinical remission | None |
| 3 | M/37 | Nephritis WHO IV, ventricular arrhythmia, polyserositis, APS, cytopenia | 30 | CY, AZA, HCQ, CSA, MTX, MMF | 38 | Relapse 18+ mo, exitus letalis 38+ mo | — |
| 4 | F/24 | Nephritis WHO V, seizures, psychosis, polyserositis, APS, cytopenia | 28 | CY, AZA, CSA | 72 | Clinical remission | None |
| 5 | F/31 | Nephritis WHO II, seizures, psychosis, APS, cytopenia | 26 | CY, AZA, MTX | 3 | Exitus letalis 3+ mo | — |
| 6 | F/30 | Nephritis WHO IIa, APS, cytopenia | 23 | CY, AZA, MTX, HQC | 48 | Clinical remission | 4 mg prednisolone |
| 7 | M/19 | Nephritis, cerebritis, APS cytopenia | 19 | CY, AZA, MTX, HCQ | 24 | Clinical remission | 4 mg prednisolone |
| Patient no. . | Sex/age, y . | Clinical manifestation . | SLEDAI pretransplantation . | Therapy pretransplantation . | Follow-up, mo . | Clinical outcome . | Current therapy . |
|---|---|---|---|---|---|---|---|
| 1 | F/27 | Nephritis, abdominal vasculitis, polyserositis, APS, cytopenia | 25 | CY, AZA, HCQ, CSA, MMF | 96 | Clinical remission | 2 mg prednisolone |
| 2 | F/48 | Nephritis, peripheral neuropathy, polyserositis, ventricular arrhythmia | 23 | CY, AZA, HCQ, MTX, MMF | 96 | Clinical remission | None |
| 3 | M/37 | Nephritis WHO IV, ventricular arrhythmia, polyserositis, APS, cytopenia | 30 | CY, AZA, HCQ, CSA, MTX, MMF | 38 | Relapse 18+ mo, exitus letalis 38+ mo | — |
| 4 | F/24 | Nephritis WHO V, seizures, psychosis, polyserositis, APS, cytopenia | 28 | CY, AZA, CSA | 72 | Clinical remission | None |
| 5 | F/31 | Nephritis WHO II, seizures, psychosis, APS, cytopenia | 26 | CY, AZA, MTX | 3 | Exitus letalis 3+ mo | — |
| 6 | F/30 | Nephritis WHO IIa, APS, cytopenia | 23 | CY, AZA, MTX, HQC | 48 | Clinical remission | 4 mg prednisolone |
| 7 | M/19 | Nephritis, cerebritis, APS cytopenia | 19 | CY, AZA, MTX, HCQ | 24 | Clinical remission | 4 mg prednisolone |
APS indicates antiphospholipid syndrome; CY, cyclophosphamide; AZA, azathioprine; HCQ, hydroxychloroquine; CSA, cyclosporine; MTX, methotrexate; MMF, mycophenolate mofetil; and —, not applicable.